From: TPX2 expression is associated with poor survival in gastric cancer
TPX2 expression | ||||
---|---|---|---|---|
n | Low (n = 167) | High (n = 123) | p value | |
Gender | ||||
Male | 219 | 127 | 92 | |
Female | 71 | 40 | 31 | 0.807 |
Age | ||||
<65 | 129 | 88 | 41 | |
≥65 | 161 | 79 | 82 | 0.001 |
Pathological type | ||||
Undifferentiated | 158 | 104 | 54 | |
Differentiated | 132 | 63 | 69 | 0.002 |
Main location | ||||
Middle or lower | 233 | 135 | 98 | |
Upper | 57 | 32 | 25 | 0.805 |
Depth of invasion | ||||
T1 | 120 | 83 | 37 | |
T2 | 37 | 22 | 15 | |
T3 | 49 | 24 | 25 | |
T4 | 84 | 38 | 46 | <0.001 |
LN metastasis | ||||
N0 | 149 | 104 | 45 | |
N1 | 44 | 26 | 18 | |
N2 | 39 | 12 | 27 | |
N3 | 58 | 25 | 33 | <0.001 |
Stage | ||||
I | 139 | 98 | 41 | |
II | 51 | 26 | 25 | |
III | 75 | 30 | 45 | |
IV | 25 | 13 | 12 | <0.001 |
Distant metastasis or recurrence | ||||
Negative | 205 | 127 | 78 | |
Positive | 85 | 40 | 45 | 0.020 |